Euglycaemic ketoacidosis in pregnant women with COVID-19: two case reports

BMC Pregnancy Childbirth. 2021 Jun 16;21(1):427. doi: 10.1186/s12884-021-03928-w.

Abstract

Background: Euglycaemic ketoacidosis (EKA) is an infrequent but serious condition which usually follows a period of starvation, severe vomiting or illness in individuals with or without diabetes. Ketoacidosis is associated with materno-fetal morbidity and mortality necessitating prompt diagnosis and management. Physiological increases in insulin resistance render pregnancy a diabetogenic state with increased susceptibility to ketosis. COVID-19 is associated with worse clinical outcomes in patients with diabetes and is an independent risk factor for ketoacidosis in normoglycaemic individuals.

Case presentations: We describe two cases of SARS-CoV-2 positive pregnant women presenting with normoglycaemic metabolic ketoacidosis. Both cases were associated with maternal and fetal compromise, requiring aggressive fluid and insulin resuscitation and early delivery.

Conclusion: We discuss possible physiology and propose a management strategy for euglycaemic ketoacidosis in pregnancy.

Keywords: COVID-19; EKA; Euglycaemic; Ketoacidosis; Pregnancy.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / complications
  • COVID-19 / diagnosis*
  • Female
  • Fluid Therapy / methods
  • Humans
  • Insulin Resistance
  • Ketosis / complications
  • Ketosis / diagnosis*
  • Ketosis / therapy
  • Maternal-Fetal Exchange
  • Pregnancy
  • Pregnancy Complications / diagnosis*
  • Pregnancy Complications / therapy
  • SARS-CoV-2
  • Starvation / complications*
  • Starvation / therapy